Comparison of claims data on hospitalization rates and repeat procedures in patients receiving a bowel preparation prior to colonoscopy

por Young, Lisa E, Sacks, Naomi C, Cyr, Philip L, Sharma, Abhishek, Dahdal, David N
Publicado 2017

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States

por Sacks, Naomi C., Healey, Bridget E., Raza, Sajjad, Cyr, Philip L., Boerner, Gerhard, Sheshadri, Ajay
Publicado 2022

Real-world comparison of the effectiveness and safety of different bowel preparation agents

por Sacks, Naomi C, Sharma, Abhishek, Cyr, Philip L, Bertiger, Gerald, Dahdal, David N, Brogadir, Stuart P
Publicado 2018

Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims

por Sacks, Naomi C, Healey, Bridget E, Cyr, Philip L, Slocomb, Theodore, James, Emma, Beggs, Alan H, Graham, Robert J
Publicado 2021

Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis

por Jensen, Ivar S., Wu, Elizabeth, Fan, Weihong, Lodise, Thomas P., Nicolau, David P., Dufour, Scott, Cyr, Philip L., Sulham, Katherine A.
Publicado 2016

Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact Analysis

por Jensen, Ivar S., Lodise, Thomas P., Fan, Weihong, Wu, Chining, Cyr, Philip L., Nicolau, David P, DuFour, Scott, Sulham, Katherine A.
Publicado 2015

Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective

por Jensen, Ivar S., Wu, Elizabeth, Cyr, Philip L., Claussen, Marc, Winkler, Thomas, Salahuddin, Khalid, Prats, Jayne, Mahaffey, Kenneth W., Gibson, Charles Michael, Steg, Philippe Gabriel, Stone, Gregg W., Bhatt, Deepak L.
Publicado 2021